Aug 14, 2024 8:00am EDT Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device
Jul 31, 2024 8:00am EDT Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
Jul 18, 2024 9:00am EDT Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us
Jun 20, 2024 8:30am EDT Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference
May 24, 2024 5:00pm EDT Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Apr 22, 2024 9:00am EDT Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
Mar 28, 2024 9:00am EDT Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Dec 18, 2023 9:00am EST Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
Oct 18, 2023 9:00am EDT Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis